We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Aciphex Approval Comes With Shared Exclusivity
Generic Aciphex Approval Comes With Shared Exclusivity
March 6, 2007
Teva Pharmaceutical will have partial marketing exclusivity once it launches rabeprazole sodium, a generic version of Eisai’s acid-pump inhibitor drug, Aciphex.